For Biden, a New Virus Dilemma: How to Handle a Looming Glut of Vaccine
As U.S. manufacturers hit their stride, vaccine scarcity will soon turn to plenty as much of the world goes begging. And vaccine makers need answers now about what to do with the coming surplus.
View original article
Contributor: Sharon LaFraniere and Noah Weiland
